Article Versions Notes

Cuevas-López B, Romero-Ramirez EI, García-Arroyo FE, Tapia E, León-Contreras JC, Silva-Palacios A, Roldán F-J, Campos ONM, Hernandez-Esquivel L, Marín-Hernández A, et al. NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3. Antioxidants. 2023; 12(8):1592. https://doi.org/10.3390/antiox12081592

Cuevas-López, Belén, Edgar Ignacio Romero-Ramirez, Fernando E. García-Arroyo, Edilia Tapia, Juan Carlos León-Contreras, Alejandro Silva-Palacios, Francisco-Javier Roldán, Omar Noel Medina Campos, Luz Hernandez-Esquivel, Alvaro Marín-Hernández, and et al. 2023. "NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3" Antioxidants 12, no. 8: 1592. https://doi.org/10.3390/antiox12081592

Cuevas-López, B., Romero-Ramirez, E. I., García-Arroyo, F. E., Tapia, E., León-Contreras, J. C., Silva-Palacios, A., Roldán, F.-J., Campos, O. N. M., Hernandez-Esquivel, L., Marín-Hernández, A., Gonzaga-Sánchez, J. G., Hernández-Pando, R., Pedraza-Chaverri, J., Sánchez-Lozada, L. G., & Aparicio-Trejo, O. E. (2023). NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3. Antioxidants, 12(8), 1592. https://doi.org/10.3390/antiox12081592